Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the
value_type as 'ranked' since this provides a very robust analysis method.
intercation map as 'high confidence'
network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1212 to 1261 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1212\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KIF13A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kinesin-like protein kif13a (kinesin-like protein rbkin). [source:swissprot;acc:q9h1h9]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.364\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
219.759\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02517\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1213\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
conserved oligomeric golgi complex component 2 (low density lipoprotein receptor defect c-complementing protein). [source:swissprot;acc:q14746]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1214\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
kinesin-like protein kif13b (kinesin-like protein gakin). [source:swissprot;acc:q9nqt8]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1215\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DAZAP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
daz associated protein 1 isoform b; deleted in azoospermia associated protein 1. [source:refseq;acc:nm\_018959]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.268\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.916\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02514\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1216\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ZMIZ1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
retinoic acid induced 17; pias-like protein hzimp10. [source:refseq;acc:nm\_020338]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.269\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.918\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02513\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1217\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
QRSL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutaminyl-trna synthase (glutamine-hydrolyzing)-like 1. [source:refseq;acc:nm\_018292]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
211.959\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.258\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.025\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1218\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FAAH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fatty-acid amide hydrolase (ec 3.1.-.-) (oleamide hydrolase) (anandamide amidohydrolase). [source:swissprot;acc:o00519]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1219\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COTL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
coactosin-like protein. [source:swissprot;acc:q14019]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1220\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UNG\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
uracil-dna glycosylase, mitochondrial precursor (ec 3.2.2.-) (udg). [source:swissprot;acc:p13051]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1221\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PET112L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
probable glutamyl-trna(gln) amidotransferase subunit b, mitochondrial precursor (ec 6.3.5.-) (glu-adt subunit b) (cytochrome oxidase assembly factor pet112 homolog). [source:swissprot;acc:o75879]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1222\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TPD52L1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tumor protein d53 (hd53) (d52-like 1). [source:swissprot;acc:q16890]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.774\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.936\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02496\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1223\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TPD52\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tumor protein d52 (n8 protein). [source:swissprot;acc:p55327]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.771\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
211.926\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02493\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1224\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FPGS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
folylpolyglutamate synthase, mitochondrial precursor (ec 6.3.2.17) (folylpoly-gamma-glutamate synthetase) (fpgs). [source:swissprot;acc:q05932]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.906\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
231.524\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02487\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1225\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBE2E1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2 e1 (ec 6.3.2.19) (ubiquitin-protein ligase e1) (ubiquitin carrier protein e1) (ubch6). [source:swissprot;acc:p51965]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
166.846\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
170.989\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02483\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1226\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBE2E4P\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2e 3; ubiquitin carrier protein; ubiquitin-protein ligase. [source:refseq;acc:nm\_006357]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1227\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PYCR2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pyrroline 5-carboxylate reductase isoform. [source:refseq;acc:nm\_013328]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
172.365\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
168.219\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02465\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1228\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GCLM\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutamate--cysteine ligase regulatory subunit (ec 6.3.2.2) (gamma- glutamylcysteine synthetase) (gamma-ecs) (gcs light chain) (glutamate--cysteine ligase modifier subunit). [source:swissprot;acc:p48507]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.079\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
218.325\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02462\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1229\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GCLC\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glutamate--cysteine ligase catalytic subunit (ec 6.3.2.2) (gamma- glutamylcysteine synthetase) (gamma-ecs) (gcs heavy chain). [source:swissprot;acc:p48506]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1230\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IL4I1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
interleukin-4 induced protein 1 precursor (fig-1 protein). [source:swissprot;acc:q96rq9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.288\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02456\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1231\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PGAM4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative phosphoglycerate mutase 3 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13). [source:swissprot;acc:q8n0y7]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.724\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.637\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0245\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1232\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PYCR1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pyrroline-5-carboxylate reductase (ec 1.5.1.2) (p5cr) (p5c reductase). [source:swissprot;acc:p32322]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
172.543\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
168.417\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1233\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphoglycerate mutase 1 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme b) (pgam-b) (bpg-dependent pgam 1). [source:swissprot;acc:p18669]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
212.724\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
207.637\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1234\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PGAM2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphoglycerate mutase 2 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme m) (pgam-m) (bpg-dependent pgam 2) (muscle-specific phosphoglycerate mutase). [source:swissprot;acc:p15259]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1235\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
keratin associated protein 9-4; keratin associated protein 9.4. [source:refseq;acc:nm\_033191]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.356\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.723\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02447\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1236\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
keratin associated protein 4-10; keratin associated protein 4.10. [source:refseq;acc:nm\_033060]\vspace{3pt}}&\multirow{26}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.354\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}}&\multirow{26}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02437\vspace{3pt}}}\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1237\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
keratin associated protein 4-2; keratin associated protein 4.2. [source:refseq;acc:nm\_033062]\vspace{3pt}}&&&\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1238\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
keratin associated protein 4.3 (fragment). [source:sptrembl;acc:q9byr4]\vspace{3pt}}&&&\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1239\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
keratin associated protein 2-4; keratin associated protein 2.4. [source:refseq;acc:nm\_033184]\vspace{3pt}}&&&\\\cline{1-1}\cline{3-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1240\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
keratin associated protein 4-14; keratin associated protein 4.14. [source:refseq;acc:nm\_033059]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}}&\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1241\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
keratin associated protein 4.9 (fragment). [source:sptrembl;acc:q9byq8]\vspace{3pt}}&&&\\\cline{1-1}\cline{3-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1242\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
keratin associated protein 4-12; keratin associated protein 4.12. [source:refseq;acc:nm\_031854]\vspace{3pt}}&&&\\\cline{1-1}\cline{3-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1243\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
keratin associated protein 1.5. [source:refseq;acc:nm\_031957]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1244\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STARD6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
star-related lipid transfer protein 6 (stard6) (start domain- containing protein 6). [source:swissprot;acc:p59095]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1245\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KRTAP5-8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
keratin, ultra high-sulfur matrix protein b (uhs keratin b) (uhs kerb). [source:swissprot;acc:o75690]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1246\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
keratin, ultra high-sulfur matrix protein a (uhs keratin a) (uhs kera). [source:swissprot;acc:p26371]\vspace{3pt}}&&&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1247\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STARD5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
star-related lipid transfer protein 5 (stard5) (start domain- containing protein 5). [source:swissprot;acc:q9nsy2]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1248\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KRTAP4-4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
keratin associated protein 4.4. [source:refseq;acc:nm\_032524]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1249\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-parvin (calponin-like integrin-linked kinase binding protein) (ch-ilkbp). [source:swissprot;acc:q9nvd7]\vspace{3pt}}&&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1250\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIMS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pinch protein (particularly interesting new cys-his protein) (lim and senescent cell antigen-like domains 1). [source:swissprot;acc:p48059]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1251\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ILK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
integrin-linked protein kinase 1 (ec 2.7.1.-) (ilk-1) (59 kda serine/threonine protein kinase) (p59ilk). [source:swissprot;acc:q13418]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1252\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STARD4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
star-related lipid transfer protein 4 (stard4) (start domain- containing protein 4). [source:swissprot;acc:q96dr4]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1253\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RSU1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ras suppressor protein 1 (rsu-1) (rsp-1). [source:swissprot;acc:q15404]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1254\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
G3BP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ras-gtpase-activating protein binding protein 1 (gap sh3-domain binding protein 1) (g3bp-1). [source:swissprot;acc:q13283]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1255\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
G3BP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ras-gtpase-activating protein binding protein 2 (gap sh3-domain binding protein 2) (g3bp-2). [source:swissprot;acc:q9un86]\vspace{3pt}}&&&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1256\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
keratin associated protein 1-3; keratin associated protein 1.3. [source:refseq;acc:nm\_030966]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
224.699\vspace{3pt}}&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1257\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ESPNP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
espin. [source:refseq;acc:nm\_031475]\vspace{3pt}}&&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
224.7\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1258\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYP2D6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytochrome p450 2d6 (ec 1.14.14.1) (cypiid6) (p450-db1) (debrisoquine 4-hydroxylase). [source:swissprot;acc:p10635]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1259\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PLEKHC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pleckstrin homology domain containing, family c (with ferm domain) member 1; mitogen inducible 2; kindlin 2. [source:refseq;acc:nm\_006832]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1260\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIMS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lim and senescent cell antigen-like domains 2; ilk-binding protein. [source:refseq;acc:nm\_017980]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1261\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DRD4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
d(4) dopamine receptor (d(2c) dopamine receptor). [source:swissprot;acc:p21917]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/